This is government healthcare rationing at its ugliest. The Food and Drug Administration in December approved two ...
The study is expected to evaluate the safety of Iomab-ACT in sickle cell disease patients who are undergoing allogeneic bone ...
Sickle cell disease is an inherited blood condition that affects Red Blood Cells (RBCs) and haemoglobin in them. Haemoglobin ...
A Johns Hopkins team has developed a gene editing approach that could make the treatment of sickle cell disease shorter and ...
CRISPR treatment for sickle cell disease carries a high risk of infertility. Vertex wants to preserve patient fertility, but ...
Another child has been treated for a deadly affliction known as the “bubble boy” disease. Dr. Moustache and his “magical team ...
Current gene therapies to treat sickle cell disease are complex, time-consuming, and are sometimes linked to serious side effects like infertility or blood cancer. To address these challenges ...
Gene therapy promises just that. It's like having a molecular mechanic that can fix or replace faulty genes, potentially ...
Complicating the lifelong condition is the shortage of SCD doctors in the United States. A 2016 survey found that only 43% of ...
Understanding of cell therapies is rapidly improving, but there remain significant challenges in getting new therapies onto the market.
Richard B. Rosen, MD, from the New York Eye and Ear Infirmary of Mount Sinai discussed his presentation on sickle cell ...
Hematology focuses on blood disorders, including anemia and leukemia, examining their impact on red and white blood cells and plasma proteins. This analysis highlights current therapies, technologies, ...